Product Type
Condition
Binding
Collectible Attributes
Free Shipping
Seller Location
Seller Rating
Published by Éditions universitaires européennes, 2018
ISBN 10: 6202261838ISBN 13: 9786202261838
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Book
Condition: New.
Published by Editions Universitaires Europeennes 1/24/2018, 2018
ISBN 10: 6202261838ISBN 13: 9786202261838
Seller: BargainBookStores, Grand Rapids, MI, U.S.A.
Book
Paperback or Softback. Condition: New. Drug resistance tuberculosis 0.25. Book.
Published by Éditions universitaires européennes, 2018
ISBN 10: 6202261838ISBN 13: 9786202261838
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Book
Condition: New.
Published by Éditions universitaires européennes, 2018
ISBN 10: 6202261838ISBN 13: 9786202261838
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Book
Condition: As New. Unread book in perfect condition.
Published by Ãditions universitaires europà ennes, 2018
ISBN 10: 6202261838ISBN 13: 9786202261838
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Verlag Unser Wissen, 2023
ISBN 10: 6205925850ISBN 13: 9786205925850
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Edições Nosso Conhecimento, 2023
ISBN 10: 6205925907ISBN 13: 9786205925904
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Editions Notre Savoir, 2023
ISBN 10: 6205925877ISBN 13: 9786205925874
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Edizioni Sapienza, 2023
ISBN 10: 6205925893ISBN 13: 9786205925898
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Editions universitaires europeennes 2018-01, 2018
ISBN 10: 6202261838ISBN 13: 9786202261838
Seller: Chiron Media, Wallingford, United Kingdom
Book
PF. Condition: New.
Published by Éditions universitaires européennes, 2018
ISBN 10: 6202261838ISBN 13: 9786202261838
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Book
Condition: New.
Published by Ediciones Nuestro Conocimiento, 2023
ISBN 10: 6205925869ISBN 13: 9786205925867
Seller: GF Books, Inc., Hawthorne, CA, U.S.A.
Book
Condition: New. Book is in NEW condition. 0.28.
Published by Ediciones Nuestro Conocimiento, 2023
ISBN 10: 6205925869ISBN 13: 9786205925867
Seller: GF Books, Inc., Hawthorne, CA, U.S.A.
Book
Condition: Very Good. Book is in Used-VeryGood condition. Pages and cover are clean and intact. Used items may not include supplementary materials such as CDs or access codes. May show signs of minor shelf wear and contain very limited notes and highlighting. 0.28.
Published by Ediciones Nuestro Conocimiento, 2023
ISBN 10: 6205925869ISBN 13: 9786205925867
Seller: GF Books, Inc., Hawthorne, CA, U.S.A.
Book
Condition: Fine. Book is in Used-LikeNew condition. Pages and cover are clean and intact. Used items may not include supplementary materials such as CDs or access codes. May show signs of minor shelf wear. 0.28.
Published by Ediciones Nuestro Conocimiento, 2023
ISBN 10: 6205925869ISBN 13: 9786205925867
Seller: Books Unplugged, Amherst, NY, U.S.A.
Book
Condition: Good. Buy with confidence! Book is in good condition with minor wear to the pages, binding, and minor marks within 0.28.
Published by Ediciones Nuestro Conocimiento, 2023
ISBN 10: 6205925869ISBN 13: 9786205925867
Seller: Books Unplugged, Amherst, NY, U.S.A.
Book
Condition: Fair. Buy with confidence! Book is in acceptable condition with wear to the pages, binding, and some marks within 0.28.
Published by Ediciones Nuestro Conocimiento, 2023
ISBN 10: 6205925869ISBN 13: 9786205925867
Seller: Book Deals, Tucson, AZ, U.S.A.
Book
Condition: New. New! This book is in the same immaculate condition as when it was published 0.28.
Published by Ediciones Nuestro Conocimiento, 2023
ISBN 10: 6205925869ISBN 13: 9786205925867
Seller: Book Deals, Tucson, AZ, U.S.A.
Book
Condition: Fine. Like New condition. Great condition, but not exactly fully crisp. The book may have been opened and read, but there are no defects to the book, jacket or pages. 0.28.
Published by Ediciones Nuestro Conocimiento, 2023
ISBN 10: 6205925869ISBN 13: 9786205925867
Seller: Book Deals, Tucson, AZ, U.S.A.
Book
Condition: Very Good. Very Good condition. Shows only minor signs of wear, and very minimal markings inside (if any). 0.28.
Published by Ediciones Nuestro Conocimiento, 2023
ISBN 10: 6205925869ISBN 13: 9786205925867
Seller: Book Deals, Tucson, AZ, U.S.A.
Book
Condition: Fair. Acceptable/Fair condition. Book is worn, but the pages are complete, and the text is legible. Has wear to binding and pages, may be ex-library. 0.28.
Published by Verlag Unser Wissen Apr 2023, 2023
ISBN 10: 6205925850ISBN 13: 9786205925850
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Multiresistente Tuberkulose ist weltweit ein großes Problem der öffentlichen Gesundheit. Trotz der Strategien (DOTS, DOTS PLUS und Stop TB), die zur Bekämpfung dieser Geißel entwickelt wurden, ist MDR-TB immer noch eine echte Bedrohung für die globalen Gesundheitsprogramme. Besonders ernst ist die Lage in den Entwicklungsländern, auf die fast 95 % der festgestellten Fälle entfallen. Das Auftreten von MDR-TB-Stämmen könnte den Erfolg der TB-Eradikationsprogramme gefährden. In Anbetracht der begrenzten Diagnose- und Follow-up-Tests für Patienten, die sich in ressourcenarmen Ländern (DRC) einer Behandlung unterziehen, haben wir zwei Tests evaluiert: den Blasenanfälligkeitstest, der die Resistenz gegen Rifampicin, Kanamycin und Ofloxacin nachweist, und die Fluoresceindiacetat-Färbetechnik, mit der nur lebensfähige Bazillen nachgewiesen werden können. Mit Hilfe von Objektträgern konnte innerhalb von 10 Tagen der Grad der Resistenz gegen Rifampicin (47,3 %), Ofloxacin (15,7 %) und Kanamycin (16,7 %) in der gesamten Population bestimmt werden. 52 pp. Deutsch.
Published by Edizioni Sapienza Apr 2023, 2023
ISBN 10: 6205925893ISBN 13: 9786205925898
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -La tubercolosi multiresistente è un grave problema di salute pubblica in tutto il mondo. Nonostante le strategie (DOTS, DOTS PLUS e Stop TB) messe in atto per combattere questo flagello, la MDR-TB è ancora una minaccia reale per i programmi di salute globale. La situazione è particolarmente grave nei Paesi in via di sviluppo, che rappresentano quasi il 95% dei casi rilevati. L'emergere di ceppi di MDR-TB potrebbe compromettere il successo dei programmi di eradicazione della TB. Date le limitazioni dei test diagnostici e di follow-up per i pazienti in trattamento nei Paesi poveri di risorse (RDC), abbiamo valutato due test: il test di suscettibilità vescicale che rileva la resistenza alla rifampicina, alla kanamicina e all'ofloxacina e la tecnica di colorazione con diacetato di fluoresceina, che consente di rivelare solo i bacilli vitali. La sensibilità del vetrino è stata in grado di determinare entro 10 giorni il livello di resistenza alla rifampicina (47,3%), all'Ofloxacina (15,7%) e alla Kanamicina (16,7%) nell'intera popolazione. 52 pp. Italienisch.
Published by Edições Nosso Conhecimento Apr 2023, 2023
ISBN 10: 6205925907ISBN 13: 9786205925904
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -A tuberculose multirresistente é um grave problema de saúde pública em todo o mundo. Apesar das estratégias (DOTS, DOTS PLUS e Stop TB) criadas para combater este flagelo, a tuberculose multirresistente continua a ser uma ameaça real para os programas de saúde mundiais. A situação é particularmente grave nos países em desenvolvimento, que representam quase 95% dos casos detectados. O aparecimento de estirpes de TB-MDR pode comprometer o êxito dos programas de erradicação da TB. Tendo em conta as limitações dos testes de diagnóstico e de acompanhamento dos doentes em tratamento nos países com poucos recursos (RDC), avaliámos dois testes: o teste de susceptibilidade da bexiga que detecta a resistência à rifampicina, à canamicina e à ofloxacina e a técnica de coloração com diacetato de fluoresceína, que permite revelar apenas os bacilos viáveis. A susceptibilidade das lâminas foi capaz de determinar, no prazo de 10 dias, o nível de resistência à rifampicina (47,3%), à ofloxacina (15,7%) e à canamicina (16,7%) em toda a população. 52 pp. Portugiesisch.
Published by Editions Notre Savoir Apr 2023, 2023
ISBN 10: 6205925877ISBN 13: 9786205925874
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -La tuberculose multirésistante est un problème majeur de santé publique dans le monde. Malgré les stratégies (DOTS, DOTS PLUS et Stop TB) mises en place pour lutter contre ce fléau, la tuberculose multirésistante reste une menace réelle pour les programmes de santé mondiaux. La situation est particulièrement grave dans les pays en développement, qui représentent près de 95 % des cas détectés. L'émergence de souches de TB-MR pourrait compromettre le succès des programmes d'éradication de la tuberculose. Compte tenu des limites des tests de diagnostic et de suivi des patients en traitement dans les pays à ressources limitées (RDC), nous avons évalué deux tests : l'antibiogramme sur lame qui détecte la résistance à la rifampicine, à la Kanamycine et à l'Ofloxacine et la technique de coloration au diacétate de Fluorescéine qui permet de ne mettre en évidence que les bacilles viables. L'antibiogramme a permis de déterminer en 10 jours le niveau de résistance à la rifampicine (47,3 %), à l'Ofloxacine (15,7 %) et à la Kanamycine (16,7 %) dans l'ensemble de la population. 52 pp. Französisch.
Published by Editions Universitaires Europeennes EUE Feb 2018, 2018
ISBN 10: 6202261838ISBN 13: 9786202261838
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Multidrug-Resistant Tuberculosis is a Major Public Health Problem Around the World, Despite Strategies (DOTS, DOTS PLUS and Stop TB) set up to fight this scourge, MDR-TB is still a real threat to Global Health Programs. The situation is particularly serious in developing countries, which account for nearly 95% of detected cases. The emergence of MDR-TB strains could jeopardize the success of TB eradication programs. Given the limitations of diagnostic and follow-up tests for patients undergoing treatment in resource-poor countries (DRC), we evaluated two tests: the bladder susceptibility test that detects resistance to rifampicin, Kanamycin and Ofloxacin and the Fluorescein diacetate staining technique, which makes it possible to reveal only viable bacilli. Slide susceptibility was able to determine within 10 days the level of rifampicin resistance (47.3%), Ofloxacin (15.7%) and Kanamycin (16.7%) in whole population. 68 pp. Englisch.
Published by Ediciones Nuestro Conocimiento Apr 2023, 2023
ISBN 10: 6205925869ISBN 13: 9786205925867
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -La tuberculosis multirresistente es un grave problema de salud pública en todo el mundo. A pesar de las estrategias (DOTS, DOTS PLUS y Stop TB) establecidas para luchar contra esta lacra, la MDR-TB sigue siendo una amenaza real para los programas de salud mundial. La situación es especialmente grave en los países en desarrollo, que representan casi el 95% de los casos detectados. La aparición de cepas de TB-MDR podría poner en peligro el éxito de los programas de erradicación de la tuberculosis. Dadas las limitaciones de las pruebas de diagnóstico y seguimiento de los pacientes en tratamiento en los países con pocos recursos (RDC), evaluamos dos pruebas: la prueba de susceptibilidad en vejiga, que detecta la resistencia a la rifampicina, la kanamicina y la ofloxacina, y la técnica de tinción con diacetato de fluoresceína, que permite revelar únicamente los bacilos viables. La susceptibilidad en portaobjetos permitió determinar en 10 días el nivel de resistencia a la rifampicina (47,3%), a la Ofloxacina (15,7%) y a la Kanamicina (16,7%) en el conjunto de la población. 52 pp. Spanisch.
Published by Éditions universitaires européennes, 2018
ISBN 10: 6202261838ISBN 13: 9786202261838
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Book
Condition: As New. Unread book in perfect condition.
Published by Verlag Unser Wissen, 2023
ISBN 10: 6205925850ISBN 13: 9786205925850
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Multiresistente Tuberkulose ist weltweit ein großes Problem der öffentlichen Gesundheit. Trotz der Strategien (DOTS, DOTS PLUS und Stop TB), die zur Bekämpfung dieser Geißel entwickelt wurden, ist MDR-TB immer noch eine echte Bedrohung für die globalen Gesundheitsprogramme. Besonders ernst ist die Lage in den Entwicklungsländern, auf die fast 95 % der festgestellten Fälle entfallen. Das Auftreten von MDR-TB-Stämmen könnte den Erfolg der TB-Eradikationsprogramme gefährden. In Anbetracht der begrenzten Diagnose- und Follow-up-Tests für Patienten, die sich in ressourcenarmen Ländern (DRC) einer Behandlung unterziehen, haben wir zwei Tests evaluiert: den Blasenanfälligkeitstest, der die Resistenz gegen Rifampicin, Kanamycin und Ofloxacin nachweist, und die Fluoresceindiacetat-Färbetechnik, mit der nur lebensfähige Bazillen nachgewiesen werden können. Mit Hilfe von Objektträgern konnte innerhalb von 10 Tagen der Grad der Resistenz gegen Rifampicin (47,3 %), Ofloxacin (15,7 %) und Kanamycin (16,7 %) in der gesamten Population bestimmt werden.
Published by Editions Universitaires Europeennes EUE, 2018
ISBN 10: 6202261838ISBN 13: 9786202261838
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Multidrug-Resistant Tuberculosis is a Major Public Health Problem Around the World, Despite Strategies (DOTS, DOTS PLUS and Stop TB) set up to fight this scourge, MDR-TB is still a real threat to Global Health Programs. The situation is particularly serious in developing countries, which account for nearly 95% of detected cases. The emergence of MDR-TB strains could jeopardize the success of TB eradication programs. Given the limitations of diagnostic and follow-up tests for patients undergoing treatment in resource-poor countries (DRC), we evaluated two tests: the bladder susceptibility test that detects resistance to rifampicin, Kanamycin and Ofloxacin and the Fluorescein diacetate staining technique, which makes it possible to reveal only viable bacilli. Slide susceptibility was able to determine within 10 days the level of rifampicin resistance (47.3%), Ofloxacin (15.7%) and Kanamycin (16.7%) in whole population.
Published by Ediciones Nuestro Conocimiento, 2023
ISBN 10: 6205925869ISBN 13: 9786205925867
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - La tuberculosis multirresistente es un grave problema de salud pública en todo el mundo. A pesar de las estrategias (DOTS, DOTS PLUS y Stop TB) establecidas para luchar contra esta lacra, la MDR-TB sigue siendo una amenaza real para los programas de salud mundial. La situación es especialmente grave en los países en desarrollo, que representan casi el 95% de los casos detectados. La aparición de cepas de TB-MDR podría poner en peligro el éxito de los programas de erradicación de la tuberculosis. Dadas las limitaciones de las pruebas de diagnóstico y seguimiento de los pacientes en tratamiento en los países con pocos recursos (RDC), evaluamos dos pruebas: la prueba de susceptibilidad en vejiga, que detecta la resistencia a la rifampicina, la kanamicina y la ofloxacina, y la técnica de tinción con diacetato de fluoresceína, que permite revelar únicamente los bacilos viables. La susceptibilidad en portaobjetos permitió determinar en 10 días el nivel de resistencia a la rifampicina (47,3%), a la Ofloxacina (15,7%) y a la Kanamicina (16,7%) en el conjunto de la población.